Trial intelligence / Profile preview

Calcitriol in Pre-diabetic Persons

NCT04286529Phase 1Terminated

Sponsor
Mayo Clinic
Start
Oct 2020
Primary completion
May 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of calcitriol in prediabetes (4 arms), sponsored by Mayo Clinic. Primary endpoints: Glucose Levels at 8 weeks, Insulin Level at 8 weeks and 1 more. Started Oct 2020; status: terminated.

02

Drugs

calcitriol
03

Conditions

prediabetes

Beyond the preview

Go deeper on NCT04286529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04286529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call